<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00571233</url>
  </required_header>
  <id_info>
    <org_study_id>2529</org_study_id>
    <nct_id>NCT00571233</nct_id>
  </id_info>
  <brief_title>Biomarker Study for Heart Failure in Children With Single Ventricle Physiology</brief_title>
  <acronym>BHFSVP</acronym>
  <official_title>Identification of Biomarkers for Heart Failure in Children With Single Ventricle Physiology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if children with heart disease where there is only
      one pumping chamber(&quot;ventricle&quot;) have proteins (biomarkers&quot;) in the blood that can be used to
      monitor the function of their heart.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will investigate whether levels of blood proteins in children with well-functioning hearts
      with one (&quot;single&quot;) ventricle are similar to levels of these blood proteins in children with
      two ventricles. For children with hearts with a single ventricle, we will examine blood
      proteins at various levels of heart function. To assess blood protein levels, we will collect
      small (6 mL) samples of blood. Heart function will be determined by existing clinical scoring
      systems. Enrolled patients will receive an echocardiogram, which is a dynamic ultrasound
      picture of the beating heart.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">January 2015</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Heart failure, as assessed by clinical scoring systems.</measure>
    <time_frame>Cross-sectional. We will obtain blood samples and assess for heart failure (function) concurrently when patients present to the Pediatric Heart Center</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic indices.</measure>
    <time_frame>Cross-sectional</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">71</enrollment>
  <condition>Tricuspid Atresia</condition>
  <condition>Hypoplastic Left Heart Syndrome</condition>
  <condition>Unbalanced AV Canal</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Group one consists of children 1 month - 6 years old who have structurally normal hearts, no heart failure, and a patent ductus arteriosus (PDA).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Group two consists of children 1 month - 6 years old who have single ventricle physiology. Children with and without heart failure may participate.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to the UCSF Pediatric Heart Center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children with a structurally normal heart and a patent ductus arteriosus.

          -  Children with single ventricle physiology.

        Exclusion Criteria:

          -  Children must not have chromosomal abnormalities. Small deletions, such as that which
             produces DiGeorge syndrome, are permissible.

          -  Children with acute intercurrent non-cardiac inflammatory illness (such as
             post-operative wound infection) are ineligible, as such conditions may cause elevated
             blood levels of the proteins under study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Harold Bernstein, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSF Pediatric Cardiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pediatric Heart Center, University of California, San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791782/?tool=pubmed</url>
    <description>Usefulness of Various Plasma Biomarkers for Diagnosis of Heart Failure in Children with Single Ventricle Physiology</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/21081737</url>
    <description>Letter by Lowenthal et al regarding article, &quot;BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial&quot;</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/22196786</url>
    <description>Usefulness of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide as Biomarkers for Heart Failure in Young Children With Single Ventricle Congenital Heart Disease</description>
  </link>
  <results_reference>
    <citation>Shah A, Feraco AM, Harmon C, Tacy T, Fineman JR, Bernstein HS. Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology. Am J Cardiol. 2009 Nov 1;104(9):1280-4. doi: 10.1016/j.amjcard.2009.06.046.</citation>
    <PMID>19840577</PMID>
  </results_reference>
  <results_reference>
    <citation>Lowenthal A, Shah A, Bernstein HS. Letter by Lowenthal et al regarding article, &quot;BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial&quot;. Circ Heart Fail. 2010 Nov;3(6):e32; author reply e33. doi: 10.1161/CIRCHEARTFAILURE.110.958470.</citation>
    <PMID>21081737</PMID>
  </results_reference>
  <results_reference>
    <citation>Lowenthal A, Camacho BV, Lowenthal S, Natal-Hernandez L, Liszewski W, Hills NK, Fineman JR, Bernstein HS. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol. 2012 Mar 15;109(6):866-72. doi: 10.1016/j.amjcard.2011.10.049. Epub 2011 Dec 22.</citation>
    <PMID>22196786</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 5, 2007</study_first_submitted>
  <study_first_submitted_qc>December 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2007</study_first_posted>
  <last_update_submitted>May 13, 2015</last_update_submitted>
  <last_update_submitted_qc>May 13, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 14, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Single Ventricle</keyword>
  <keyword>Congenital Heart Disease</keyword>
  <keyword>Children</keyword>
  <keyword>Fontan</keyword>
  <keyword>Tricuspid Atresia</keyword>
  <keyword>Hypoplastic Left Heart Syndrome</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Single ventricle physiology such as:</keyword>
  <keyword>unbalanced AV canal</keyword>
  <keyword>Interested in patients both before and after Fontan Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypoplastic Left Heart Syndrome</mesh_term>
    <mesh_term>Tricuspid Atresia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

